{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "PHAT",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 237974000
            },
            {
                "label": "Prepaid expenses and other current assets (including related party amounts of $0 and $82, respectively)",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 4836000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 242810000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 907000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 2261000
            },
            {
                "label": "Other long-term assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 385000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 246363000
            },
            {
                "label": "Accounts payable (including related party amounts of $335 and $173, respectively)",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 10857000
            },
            {
                "label": "Accrued clinical trial expenses current.",
                "concept": "phat:AccruedClinicalTrialExpensesCurrent",
                "unit": "usd",
                "value": 10868000
            },
            {
                "label": "Accrued expenses (including related party amounts of $1,000 and $734, respectively)",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 6566000
            },
            {
                "label": "Accrued interest",
                "concept": "InterestPayableCurrent",
                "unit": "usd",
                "value": 312000
            },
            {
                "label": "Current portion of long-term debt",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 11765000
            },
            {
                "label": "Operating lease liabilities, current",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 477000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 40845000
            },
            {
                "label": "Long-term debt, net of discount",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 35587000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1467000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 4125000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 82024000
            },
            {
                "label": "Commitments and contingencies (Note 4)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.0001 par value; authorized shares \u2014 40,000,000 at March 31, 2021 and December 31, 2020 ; no shares issued and outstanding at March 31, 2021 and December 31, 2020",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.0001 par value; authorized shares \u2014 400,000,000; issued shares \u2014 31,321,613 and 31,262,769 at March 31, 2021 and December 31, 2020, respectively; outstanding shares \u2014 28,876,510 and 28,516,010 at March 31, 2021 and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 584666000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -420330000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 164339000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 246363000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -34843000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 3818000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 364000
            },
            {
                "label": "Change in fair value of warrant liabilities",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other",
                "concept": "OtherExpenses",
                "unit": "usd",
                "value": 357000
            },
            {
                "label": "Prepaid expenses and other current assets (includes the change in related party amounts of $82, and $0, respectively)",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 965000
            },
            {
                "label": "Accounts payable and accrued expenses (includes the change in related party amounts of $428, and $289, respectively)",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -9516000
            },
            {
                "label": "Increase decrease in clinical accrued trial expenses.",
                "concept": "phat:IncreaseDecreaseInClinicalAccruedTrialExpenses",
                "unit": "usd",
                "value": -9129000
            },
            {
                "label": "Increase (decrease) in operating right of use asset and lease liabilities.",
                "concept": "phat:IncreaseDecreaseInOperatingRightOfUseAssetAndLeaseLiabilities",
                "unit": "usd",
                "value": 25000
            },
            {
                "label": "Other long-term assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -49765000
            },
            {
                "label": "Cash paid for property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 169000
            },
            {
                "label": "Cash flows from investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -169000
            },
            {
                "label": "Proceeds from issuance of common stock from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 412000
            },
            {
                "label": "Cash flows from financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 412000
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -49522000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 906000
            },
            {
                "label": "Property and equipment purchases included in accounts payable and accrued liabilities",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 21000
            },
            {
                "label": "NonCash settlement of employee stock purchase plan liability in common stock.",
                "concept": "phat:NonCashSettlementOfEmployeeStockPurchasePlanLiabilityInCommonStock",
                "unit": "usd",
                "value": 358000
            },
            {
                "label": "NonCash settlement of defined contribution plan liability in common stock.",
                "concept": "phat:NonCashSettlementOfDefinedContributionPlanLiabilityInCommonStock",
                "unit": "usd",
                "value": 323000
            }
        ],
        "ic": [
            {
                "label": "Research and development (includes related party amounts of $939 and $404 respectively)",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 20580000
            },
            {
                "label": "General and administrative (includes related party amounts of $16 and $43, respectively)",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 13004000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 33584000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -33584000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1272000
            },
            {
                "label": "Change in fair value of warrant liabilities",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other income (expense)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Other income (expense):",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1259000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -34843000
            },
            {
                "label": "Net loss per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.96
            },
            {
                "label": "Weighted-average shares of common stock outstanding, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 36298968
            }
        ]
    }
}